New medical big data for P4 medicine on allergic conjunctivitis

New medical big data for P4 medicine on allergic conjunctivitis

Allergic conjunctivitis affects approximately 15–20% of the global population and can permanently deteriorate one's quality of life (QoL) and work productivity, leading to societal work force costs. Although not fully understood, allergic conjunctivitis is a multifactorial disease with a comple...

Full description

Bibliographic Details
Main Authors: Takenori Inomata, Jaemyoung Sung, Masahiro Nakamura, Kumiko Fujisawa, Kaori Muto, Nobuyuki Ebihara, Masao Iwagami, Kenta Fujio, Yuichi Okumura, Mitsuhiro Okano, Akira Murakami
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Allergology International
Subjects:
Allergic conjunctivitis
Mobile health
Multi-omics
Patient and public involvement
P4 medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893020300897

Internet

http://www.sciencedirect.com/science/article/pii/S1323893020300897

Similar Items